-This is a new proposal for the Pediatric AIDS Clinical Trials Unit at the University of Puerto Rico, School of Medicine. Our main objective is to comply and collaborate with the Pediatric AIDS Clinical Trials Group Research Agenda. Through the ACTG Clinical Trials Protocols we enroll pediatric HIV infected patients and HIV-infected pregnant women to perinatal studies, contributing to the research protocols. Our unit follows the design and methods specified by each of the ACTG protocols to comply with each study requirements. In the last 4 years we have enrolled 164 patients to PACTG Protocols with an excellent retention rate. Our unit has been able to maintain a performance in the excellent range through 1995-96. Our Pediatric AIDS Program/PACTU located at the University Pediatric Hospital (UPH) has a multidisciplinary staff to serve the patient population, that consists of physicians, (pediatrics and pediatric infectious diseases), nurses, pharmacists, nutritionist and administrative and data management personnel. We are participants of the Women and Infants Transmission Study since 1989; enrolling over 50 HIV infected pregnant women per year. Our unit receives referrals of HIV infected children throughout public and private agencies and community based organizations to enter clinical trials. We evaluate an average of 58 new pediatric patients per year. We have the capability to enroll over 10 new parents per year to PACTG protocols and over 12 pregnant women to ACTG perinatal protocols. Our unit has the ability to comply with all the goals of the Pediatric AIDS Clinical Trials Group.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-OTP-A (01))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Puerto Rico Med Sciences
Schools of Medicine
San Juan
United States
Zip Code
Melendez, Margarita; Blanco, Raul; Delgado, Wilfredo et al. (2006) Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 50:835-40
Hillyer, George V; Febo, Irma; Diaz, Clemente (2002) The rapid diagnosis of HIV-1 infection in mothers in Puerto Rico: a crucial testing strategy for maximal reduction of perinatal transmission. P R Health Sci J 21:133-5
Rodriguez, J F; Rodriguez, J L; Escobales, N et al. (2000) Total plasma homocysteine concentrations in Puerto Rican patients with presumptive atherosclerotic coronary disease. P R Health Sci J 19:253-8
Rodriguez, J F; Rodriguez, J L; Santana, J et al. (2000) Simultaneous quantitation of intracellular zidovudine and lamivudine triphosphates in human immunodeficiency virus-infected individuals. Antimicrob Agents Chemother 44:3097-100
Zorrilla, C D (2000) Antiretroviral combination therapy in HIV-1 infected women and men: are their responses different? Int J Fertil Womens Med 45:195-9
Rodriguez Orengo, J F; Santana, J; Febo, I et al. (2000) Intracellular studies of the nucleoside reverse transcriptase inhibitor active metabolites: a review. P R Health Sci J 19:19-27
Font, E; Rosario, O; Santana, J et al. (1999) Determination of zidovudine triphosphate intracellular concentrations in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals by tandem mass spectrometry. Antimicrob Agents Chemother 43:2964-8
Rodriguez, J F; Cordero, J; Chantry, C et al. (1998) Plasma glutathione concentrations in children infected with human immunodeficiency virus. Pediatr Infect Dis J 17:236-41
Chantry, C J; Cooper, E R; Pelton, S I et al. (1995) Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J 14:382-7